Predictions
Slack Technologies Inc.
Start price
Target price
Perf. (%)
€35.50
01.12.20
01.12.20
€25.00
01.12.21
01.12.21
8.93%
02.12.21
02.12.21
Knorr-Bremse AG
Start price
Target price
Perf. (%)
€107.68
30.11.20
30.11.20
-
29.11.23
29.11.23
-18.44%
24.01.22
24.01.22
Could be worthwhile Investment >10% per year
Jumia Technologies AG
Start price
Target price
Perf. (%)
€30.80
29.11.20
29.11.20
€40.00
04.11.21
04.11.21
-48.38%
05.11.21
05.11.21
Maxeon Solar Technologies Ltd.
Start price
Target price
Perf. (%)
€20.60
29.11.20
29.11.20
€40.00
04.11.21
04.11.21
7.28%
05.11.21
05.11.21
Aileron Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.90
28.11.20
28.11.20
€1.30
28.11.21
28.11.21
-42.22%
29.11.21
29.11.21
Everfuel A/S
Start price
Target price
Perf. (%)
€6.20
28.11.20
28.11.20
-
28.11.21
28.11.21
83.06%
16.02.21
16.02.21
Business model of the past or high risk
Below average Marketposition
Risky Investment
Significant cyclical dependencies
Plastiques Du Val De Loire Sa
Start price
Target price
Perf. (%)
€6.09
28.11.20
28.11.20
€7.00
28.11.21
28.11.21
-3.78%
29.11.21
29.11.21
Could be worthwhile Investment >10% per year
STS Group AG
Start price
Target price
Perf. (%)
€4.82
27.11.20
27.11.20
-
-5.39%
11.12.20
11.12.20
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
STS Group AG
Start price
Target price
Perf. (%)
€4.61
27.11.20
27.11.20
€5.00
4.56%
27.11.20
27.11.20
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
Navya S.a.
Start price
Target price
Perf. (%)
€4.50
26.11.20
26.11.20
€5.00
-29.33%
26.01.21
26.01.21
Risky Investment
STS Group AG
Start price
Target price
Perf. (%)
€4.56
25.11.20
25.11.20
€5.00
1.10%
27.11.20
27.11.20
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
Ecmoho Ltd.
Start price
Target price
Perf. (%)
€2.10
24.11.20
24.11.20
-
24.11.21
24.11.21
-34.76%
02.06.21
02.06.21
Probably not worthwhile Investment
Dermapharm Holding SE
Start price
Target price
Perf. (%)
€54.09
24.11.20
24.11.20
€59.00
24.11.21
24.11.21
28.86%
06.08.21
06.08.21
Equillium Inc.
Start price
Target price
Perf. (%)
€4.42
23.11.20
23.11.20
€5.50
23.11.21
23.11.21
-9.05%
10.12.20
10.12.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet